Download PDF
Thromb Haemost 1996; 75(06): 972-973
DOI: 10.1055/s-0038-1650404
Letter to the Editor
Schattauer GmbH Stuttgart

Increased Plasma Thrombomodulin in Different Subgroups of Patients with Antiphospholipid and Anti β2 Glycoprotein I Antibodies

M E Martinuzzo
University Institute of Biomedical Sciences, Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
,
R R Forastiero
University Institute of Biomedical Sciences, Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
,
L O Carreras
University Institute of Biomedical Sciences, Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina
› Author Affiliations
Further Information

Publication History

Received 08 January 1995

Accepted after revision 27 February 1996

Publication Date:
11 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4749
    PubMedGoogle Scholar
  • 2 Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-2181
    CrossrefPubMedGoogle Scholar
  • 3 Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-623
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Boheme MWJ, Nawroth PP, Kling E, Lin J, Amiral J, Riedesel J, Raeth U, Scherbaum WA. Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 4: 572-577
    PubMedGoogle Scholar
  • 5 Ohdama S, Yoshizawa Y, Kubota T, Aoki N. Plasma thrombomodulin as an indicator of thromboembolic disease in systemic lupus erythematosus. Int J Cardiol 1994; 47 (Suppl. 01) 1-6
    CrossrefPubMedGoogle Scholar
  • 6 Triplett DA. Antiphospholipid - protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31
    CrossrefPubMedGoogle Scholar
  • 7 Martinuzzo ME, Forastiero RR, Carreras LO. Anti β2 Glycoprotein I antibodies: Detection and association with thrombosis. Br J Haematol 1995; 89: 397-402
    CrossrefPubMedGoogle Scholar
  • 8 Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024-2029
    PubMedGoogle Scholar
  • 9 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Harris EN. The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibodies (KAPS) Study Group. Am J Clin Pathol 1990; 94: 476-484
    CrossrefPubMedGoogle Scholar
  • 11 Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani Ch, Kumabashiri I, Morishita E, Aoshima K, Ikeda T, Matsuda T. Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost 1994; 71: 424-427
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Karmochkine M, Boffa MC, Piette JC, Cacoub P, Wechsler B, Godeau P, Juhan I, Weiller PJ. Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies. Blood 1992; 79: 837-838
    PubMedGoogle Scholar
  • 13 Carreras LO, Maclouf J. The lupus anticoagulant and eicosanoids. Prostaglandins Leukotrienes and Essential Fatty Acids 1993; 49: 483-488
    CrossrefPubMedGoogle Scholar
  • 14 Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993; 71: 423-431
    CrossrefPubMedGoogle Scholar